| Brainstem lesions in clinically isolated syndromes M Tintore, A Rovira, G Arrambide, R Mitjana, J Río, C Auger, C Nos, ... Neurology 75 (21), 1933-1938, 2010 | 228 | 2010 |
| Clinical impact of early brain atrophy in clinically isolated syndromes F Pérez-Miralles, J Sastre-Garriga, M Tintoré, G Arrambide, C Nos, ... Multiple Sclerosis Journal 19 (14), 1878-1886, 2013 | 144 | 2013 |
| Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes A Vidal-Jordana, J Sastre-Garriga, F Pérez-Miralles, C Tur, M Tintoré, ... Multiple Sclerosis Journal 19 (9), 1175-1181, 2013 | 111 | 2013 |
| Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation E Beltrán, B Obermeier, M Moser, F Coret, M Simó-Castelló, I Boscá, ... Brain 137 (Pt10), 2703-2714, 2014 | 88 | 2014 |
| Peripheral nerve hyperexcitability: a clinical and immunologic study of 38 patients I Rubio-Agusti, F Perez-Miralles, T Sevilla, N Muelas, MJ Chumillas, ... Neurology 76 (2), 172-178, 2011 | 78 | 2011 |
| Incidence of and risk factors for neurologic complications after heart transplantation F Perez-Miralles, JC Sanchez-Manso, L Almenar-Bonet, ... Transplantation proceedings 37 (9), 4067-4070, 2005 | 63 | 2005 |
| Combined cerebrospinal fluid neurofilament light chain protein and chitinase-3 like-1 levels in defining disease course and prognosis in multiple sclerosis S Gil-Perotin, J Castillo-Villalba, L Cubas-Nuñez, R Gasque, D Hervas, ... Frontiers in neurology 10, 1008, 2019 | 61 | 2019 |
| Cognitive impairment in multiple sclerosis: Diagnosis and monitoring V Meca-Lallana, F Gascón-Giménez, RC Ginestal-López, Y Higueras, ... Neurological Sciences, 1-11, 2021 | 59 | 2021 |
| Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis S Malhotra, MF Bustamante, F Pérez-Miralles, J Rio, MC Ruiz de Villa, ... PloS one 6 (8), e23634, 2011 | 55 | 2011 |
| Efficacy and safety of rituximab in relapsing and progressive multiple sclerosis: a hospital-based study C Alcalá, F Gascón, F Pérez-Miralles, S Gil-Perotín, A Navarré, I Boscá, ... Journal of Neurology, 2018 | 54 | 2018 |
| Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis B Casanova, I Jarque, F Gascón, JC Hernández-Boluda, F Pérez-Miralles, ... Neurological Sciences 38 (7), 1213-1221, 2017 | 52 | 2017 |
| Significant clinical worsening after natalizumab withdrawal: Predictive factors. À Vidal-Jordana, M Tintoré, C Tur, F Pérez-Miralles, C Auger, J Río, ... Multiple Sclerosis Journal 21 (6), 780-785, 2014 | 52 | 2014 |
| Longitudinally extensive transverse myelitis with AQP4 antibodies revealing ovarian teratoma M Frasquet, L Bataller, E Torres-Vega, M Durán-Moreno, ... Journal of neuroimmunology 263 (1-2), 145-147, 2013 | 45 | 2013 |
| Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies F Coret, FC Pérez-Miralles, F Gascón, C Alcalá, A Navarré, A Bernad, ... Multiple Sclerosis Journal – Experimental, Translational and Clinical 4 (2 …, 2018 | 44 | 2018 |
| Predictive value of early brain atrophy on response in patients treated with interferon β FC Pérez-Miralles, J Sastre-Garriga, A Vidal-Jordana, J Río, C Auger, ... Neuroimmunology & Neuroinflammation 2 (4), e132, 2015 | 44 | 2015 |
| Use of 2 hydroxypropyl-beta-cyclodextrin therapy in two adult Niemann Pick Type C patients AA García-Robles, MJ Company-Albir, JE Megías-Vericat, ... Journal of the neurological sciences 366, 65-67, 2016 | 38 | 2016 |
| Early experience with compassionate use of 2 hydroxypropyl-beta-cyclodextrin for Niemann–Pick type C disease: review of initial published cases JE Megías-Vericat, A García-Robles, MJ Company-Albir, ... Neurological Sciences 38 (5), 727-743, 2017 | 35 | 2017 |
| Clinical experiences with cannabinoids in spasticity management in multiple sclerosis LL Fernández, EM Boquet, F Perez-Miralles, IG Gómez, ME Roig, ... Neurología (English Edition) 29 (5), 257-260, 2014 | 34 | 2014 |
| Estudio observacional sobre la efectividad y seguridad del natalizumab en el tratamiento de la esclerosis múltiple A Horga, J Castilló, J Río, M Tintoré, C Auger, J Sastre-Garriga, MC Edo, ... Rev Neurol 52, 321-30, 2011 | 34* | 2011 |
| Potential Role of CHI3L1+ Astrocytes in Progression in MS L Cubas-Núñez, S Gil-Perotín, J Castillo-Villalba, V López, ... Neurology Neuroimmunology Neuroinflammation 8 (3), e972, 2021 | 32 | 2021 |
Xavier MontalbanVerified email at cem-cat.org
